Humanized zebrafish enhance human hematopoietic stem cell survival and promote acute myeloid leukemia clonal diversity.


Journal

Haematologica
ISSN: 1592-8721
Titre abrégé: Haematologica
Pays: Italy
ID NLM: 0417435

Informations de publication

Date de publication:
01 10 2020
Historique:
aheadofprint: 19 12 2019
entrez: 15 10 2020
pubmed: 16 10 2020
medline: 28 4 2021
Statut: epublish

Résumé

Xenograft models are invaluable tools in establishing the current paradigms of hematopoiesis and leukemogenesis. The zebrafish has emerged as a robust alternative xenograft model but, like mice, lack specific cytokines that mimic the microenvironment found in human patients. To address this critical gap, we generated the first humanized zebrafish that express human hematopoietic-specific cytokines (GM-CSF, SCF, and SDF1α). Termed GSS fish, these zebrafish promote survival, self-renewal and multilineage differentiation of human hematopoietic stem and progenitor cells and result in enhanced proliferation and hematopoietic niche-specific homing of primary human leukemia cells. Using error-corrected RNA sequencing, we determined that patient-derived leukemias transplanted into GSS zebrafish exhibit broader clonal representation compared to transplants into control hosts. GSS zebrafish incorporating error-corrected RNA sequencing establish a new standard for zebrafish xenotransplantation that more accurately recapitulates the human context, providing a more representative cost-effective preclinical model system for evaluating personalized response-based treatment in leukemia and therapies to expand human hematopoietic stem and progenitor cells in the transplant setting.

Identifiants

pubmed: 33054079
doi: 10.3324/haematol.2019.223040
pmc: PMC7556680
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2391-2399

Commentaires et corrections

Type : CommentIn

Références

Immunity. 2007 May;26(5):537-41
pubmed: 17521579
Blood. 2000 Jun 1;95(11):3289-96
pubmed: 10828007
Haematologica. 2015 Jan;100(1):70-6
pubmed: 25281505
Cell Stem Cell. 2008 Feb 7;2(2):183-9
pubmed: 18371439
Nature. 2014 Feb 20;506(7488):328-33
pubmed: 24522528
J Allergy Clin Immunol. 2016 Sep;138(3):769-779
pubmed: 27139822
Methods Mol Biol. 2016;1451:171-89
pubmed: 27464808
Blood. 1989 Jul;74(1):42-8
pubmed: 2665839
Immunity. 2006 Dec;25(6):977-88
pubmed: 17174120
Oncogene. 2016 Jan 21;35(3):290-300
pubmed: 25893296
Leukemia. 2004 Feb;18(2):341-7
pubmed: 14628073
Leukemia. 2010 Oct;24(10):1785-8
pubmed: 20686503
Clin Cancer Res. 2003 Sep 15;9(11):4227-39
pubmed: 14519650
Nature. 2012 Mar 28;483(7391):603-7
pubmed: 22460905
Haematologica. 2011 Apr;96(4):612-6
pubmed: 21228037
J Exp Med. 2013 Dec 16;210(13):2843-50
pubmed: 24297996
Nature. 2007 Jun 21;447(7147):1007-11
pubmed: 17581586
Proc Natl Acad Sci U S A. 2011 Feb 8;108(6):2390-5
pubmed: 21262803
Cancer Discov. 2014 Sep;4(9):998-1013
pubmed: 25185190
Angiogenesis. 2006;9(3):139-51
pubmed: 17051341
Proc Natl Acad Sci U S A. 2011 Feb 8;108(6):2378-83
pubmed: 21262827
PLoS Biol. 2004 Mar;2(3):E75
pubmed: 15024423
Nature. 1995 Oct 19;377(6550):591-4
pubmed: 7566171
Science. 2004 Apr 2;304(5667):104-7
pubmed: 15064419
Sci Rep. 2016 Nov 25;6:37827
pubmed: 27886253
Blood. 2013 Dec 5;122(24):3918-28
pubmed: 24128862
Nat Med. 1997 Jul;3(7):730-7
pubmed: 9212098
Blood. 2011 Jul 21;118(3):766-74
pubmed: 21622651
Stem Cells Dev. 2016 Apr 1;25(7):530-41
pubmed: 26879149
Nature. 2013 Mar 14;495(7440):227-30
pubmed: 23434756
Cancer Res. 2016 Jan 15;76(2):463-71
pubmed: 26744527
Dev Cell. 2020 Feb 24;52(4):446-460.e5
pubmed: 32032546
Science. 1992 Feb 28;255(5048):1137-41
pubmed: 1372131
Blood. 2000 Apr 15;95(8):2491-8
pubmed: 10753826
Nat Med. 1996 Dec;2(12):1329-37
pubmed: 8946831
Nature. 1998 Jun 11;393(6685):595-9
pubmed: 9634238
Br J Haematol. 2011 Jun;153(6):786-9
pubmed: 21517816
Cancer Res. 2013 Sep 1;73(17):5315-9
pubmed: 23733750
J Clin Invest. 2000 Dec;106(11):1331-9
pubmed: 11104786
Cell Signal. 2005 Apr;17(4):497-506
pubmed: 15601627
Nature. 1996 Aug 15;382(6592):635-8
pubmed: 8757135
F1000Res. 2018 May 15;7:594
pubmed: 29946444
Dis Model Mech. 2016 Feb;9(2):141-53
pubmed: 26744352
Sci Transl Med. 2014 Dec 10;6(266):266ra170
pubmed: 25504881
Nature. 2013 Apr 25;496(7446):498-503
pubmed: 23594743
Hum Genomics. 2010 Oct;5(1):30-55
pubmed: 21106488

Auteurs

Vinothkumar Rajan (V)

Department of Microbiology and Immunology, Dalhousie University, Halifax, Canada.

Nicole Melong (N)

Department of Pediatrics, University of Ottawa, Ottawa, Canada.

Wing Hing Wong (W)

Department of Pediatrics, Division of Hematology-Oncology, Washington University, St. Louis, USA.

Benjamin King (B)

Department of Ocean Sciences, Memorial University, Newfoundland, Canada.

Spencer R Tong (SR)

MRC, Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, UK.

Nithin Mahajan (N)

Department of Pediatrics, Division of Hematology-Oncology, Washington University, St. Louis, USA.

Daniel Gaston (D)

Departments of Pathology, Dalhousie University, Halifax, Canada.

Troy Lund (T)

Department of Pediatrics, University of Minnesota, Minneapolis, USA.

David Rittenberg (D)

Department of Obstetrics and Gynecology, IWK Health Science Centre, Halifax, Canada.

Graham Dellaire (G)

Dept. of Pathology and Biochemistry and Molecular Biology, Dalhousie University, Halifax, Canada.

Clinton J V Campbell (CJV)

Stem Cell and Cancer Research Institute, McMaster University, Canada.

Todd Druley (T)

Department of Pediatrics, Division of Hematology-Oncology, Washington University, St. Louis, USA.

Jason N Berman (JN)

University of Ottawa and Dalhousie University, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH